About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Ways Found to Suppress Cancer Immunity

by Bidita Debnath on December 2, 2016 at 10:59 PM
Font : A-A+

 New Ways Found to Suppress Cancer Immunity

Previous studies have identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, contrary to that researchers from University of California reveal a surprising role for these enzymes in subduing cancer immunity.

Published in the journal Cell, the findings could have a clinical role in improving efficiency of immunotherapy drugs. "Before our study, no one knew that the Hippo pathway was regulating immunogenicity," said first author Toshiro Moroishi. Adding, "LATS1/2 deletion in cancer cells improves tumor immunogenicity, leading to the destruction of cancerous cells by enhancing anti-tumor immune responses."

Advertisement


Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal but dysregulation contributes to cancer development. In vitro studies of Hippo pathway kinases LATS1/2 showed that the loss of these enzymes promoted cell proliferation and tumor survival. In vivo research using immune-compromised mouse models also supports a tumor suppressor function of the Hippo pathway.

However, when Moroishi and team deleted LATS1/2 from mouse cancer cells and examined tumor growth in models with healthy immune systems researchers found that immunogenicity -- the ability to stimulate an immune response -- improved, destroying cancer cells. Researchers caution that immune systems of mouse models are different from the human immune system so the response might be different and further studies are needed.
Advertisement

If the outcome proves to be the same, using a LATS1/2 inhibitor alone or in combination with an immune checkpoint inhibitor may stimulate the immune system of patients that previously did not respond to immunotherapy treatments. Currently, most immunotherapy research focuses on targeting the immune system, but the new findings reveal that tumor cells may also be vulnerable to inhibitors.

"Inhibiting LATS1/2 could be an attractive approach to treat cancer," said Kun-Liang Guan. Adding, "LATS is an ideal target because there are many kinase inhibitors that have been successfully developed as cancer drugs."

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Myasthenia Gravis Blood Group Diet Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Boils - Treatment by Drugs Immune Checkpoint Inhibitors for Cancer Treatment 

Most Popular on Medindia

Sanatogen Selfie Addiction Calculator Nutam (400mg) (Piracetam) Blood Pressure Calculator A-Z Drug Brands in India The Essence of Yoga Sinopril (2mg) (Lacidipine) Accident and Trauma Care Blood Donation - Recipients Find a Hospital
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Ways Found to Suppress Cancer Immunity Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests